SCHEMBL3829338

SCHEMBL3829338

O=C(O)/C=C(/O)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.70
CA2 P00918 3/20 0.67
CA12 O43570 2/20 0.67
CA1 P00915 2/20 0.67
CA9 Q16790 2/20 0.67
CYP3A4 P08684 3/20 0.55
MAPT P10636 3/20 0.55
KDM4E B2RXH2 2/20 0.55
HPGD P15428 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
NPC1 O15118 1/20 0.52
GAA P10253 1/20 0.52
RAB9A P51151 1/20 0.52
CES1 P23141 3/20 0.50
ALDH1A1 P00352 2/20 0.50
CES2 O00748 2/20 0.50
TSHR P16473 2/20 0.50
DAO P14920 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2593117 1.00 NFE2L2 (0.70) NFE2L2CA2CA12CA1CA9
SCHEMBL243722 1.00 NFE2L2 (0.70) NFE2L2CA2CA12CA1CA9
SCHEMBL9781094 0.84 NFE2L2 (0.70) NFE2L2CA2CA12CA1CA9
SCHEMBL3244802 0.82 NFE2L2 (1.00) NFE2L2CA2CA12CA1CA9
SCHEMBL6426228 0.82 NFE2L2 (1.00) NFE2L2CA2CA12CA1CA9
SCHEMBL464633 0.82 NFE2L2 (1.00) NFE2L2CA2CA12CA1CA9
SCHEMBL7598129 0.80 CA2 (0.54) NFE2L2CA2CA12CA1CA9
SCHEMBL14462260 0.80 NFE2L2 (0.64) NFE2L2CA2CA12CA1CA9
SCHEMBL668443 0.80 NFE2L2 (0.64) NFE2L2CA2CA12CA1CA9
SCHEMBL11498687 0.80 NFE2L2 (0.64) NFE2L2CA2CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797072-A4 PYRAZOLE KINASE MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2009-09-09 EP disclosed
EP-1797072-A2 PYRAZOLE KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2007-06-20 EP disclosed
WO-2006033943-A2 PYRAZOLE KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC (US) 2006-03-30 WO disclosed